AKF-1 Ophthalmic Solution

· Akorn, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AKF-1 Ophthalmic Solution, covering 2013-07-18 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis [Phase 3]

See pricing